MCM
ARNA

MV Capital Management’s Arena Pharmaceuticals Inc ARNA Stock Holding History

MV Capital Management’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-18
Closed -$1K – 378
2019
Q4 		$1K Hold
18
– – ﹤0.01% 356
2019
Q3 		$1K Buy
+18
New +$1.01K ﹤0.01% 388

Other funds holding ARNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

MV Capital Management's ARNA Position: Q1 2020 in Review

MV Capital Management sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2020, closing a stake of 18 shares — an estimated $1K sold.

MV Capital Management first reported a position in ARNA in Q3 2019 and held it in 2 quarters. The position peaked at $1K in Q4 2019. 219 funds tracked by Wall St. Rank hold ARNA as of Q1 2020.

  • MV Capital Management reported no remaining Arena Pharmaceuticals Inc position as of Q1 2020 after selling out during the quarter.
  • MV Capital Management sold 18 Arena Pharmaceuticals Inc shares in Q1 2020, an estimated $1K.
  • MV Capital Management first reported a position in Arena Pharmaceuticals Inc in Q3 2019 and held it in 2 quarters.
  • MV Capital Management's Arena Pharmaceuticals Inc position peaked at $1K in Q4 2019.
  • 219 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2020.

Based on MV Capital Management's 13F filing for Q1 2020, filed 28 Apr 2020.